Advance Prescriptions for Oral COVID-19 Antiviral Medicines 12 Aug 2022
Guidance for relevant appropriately qualified prescribers and pharmacists.
On 14 July 2022, the Minister for COVID-19 Response Hon Dr Ayesha Verrall announced that eligible patients could receive an advance (“back pocket”) prescription for the following oral COVID-19 antiviral medicines - Nirmatrelvir with ritonavir (Paxlovid) and Molnupiravir (Lagevrio).
The purpose of this guidance document is to:
1. Clarify when and why this may be appropriate; and
2. Provide additional guidance and support for prescribers and pharmacists.
Click here to read the document in full
Back to latest